• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

危地马拉一家大容积眼科中心医护人员中 SARS-CoV-2 的血清流行率。

SARS-CoV-2 seroprevalence in healthcare workers in a high-volume ophthalmology centre in Guatemala.

机构信息

Department of Ophthalmology, Unidad Nacional de Oftalmología, Guatemala City, Guatemala.

出版信息

Ann Med. 2021 Dec;53(1):1956-1959. doi: 10.1080/07853890.2021.1993325.

DOI:10.1080/07853890.2021.1993325
PMID:34727801
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8567863/
Abstract

PURPOSE

To determine the seroprevalence of SARS-CoV-2 antibodies in eye healthcare workers (EHCW) in the largest ophthalmology centre in Guatemala and factors associated with antibody positivity.

METHODS

We conducted a cross sectional sero-survey in all the staff at the largest ophthalmology centre in Guatemala. Serum samples were collected and tested for total antibodies against SARS-CoV-2 employing Roche Elecsys Anti-SARS-CoV-2 Immunoassay. Results were reported as reactive or non-reactive. According to patient exposure the staff were divided into low risk (technicians, domestic and administrative staff) and high risk (nurses, ophthalmologists, anaesthesiologists, and optometrists). Among those with positive antibodies, they were given a survey that included demographic characteristics, COVID-19 exposure, and related symptomatology. Logistic regression was used to determine the factors associated with antibody positivity.

RESULTS

On November 25th a total of 94 healthcare workers were sero-surveyed, mean age was 34.15 years (±8.41), most (57.44%) were females. Seroprevalence was 18%, the majority (77%) were in the low-risk group; while 64% at high-risk, tested negative. Those at low exposure, were five times more likely to have antibodies than those at high exposure (OR:5.69; 95% CI 1.69-19.13). Age and gender were not associated to seropositivity.

CONCLUSIONS

We found a similar seroprevalence of SARS-CoV-2 antibodies in EHCW to what has been reported in other healthcare groups. Seropositivity was higher among HCW with fewer patient exposure, hence the probability of community transmission.Key messagesEven though eye healthcare workers are believed to be at higher risk of infection, the prevalence of antibodies against SARS-CoV-2 in this group is comparable to what has been reported previously in other healthcare groups.

摘要

目的

在危地马拉最大的眼科中心确定眼科医护人员(EHCW)中 SARS-CoV-2 抗体的血清阳性率和与抗体阳性相关的因素。

方法

我们对危地马拉最大的眼科中心的所有工作人员进行了横断面血清学调查。采集血清样本,采用罗氏 Elecsys Anti-SARS-CoV-2 免疫分析法检测针对 SARS-CoV-2 的总抗体。结果报告为反应性或非反应性。根据患者接触情况,工作人员分为低风险(技术员、内勤和行政人员)和高风险(护士、眼科医生、麻醉师和验光师)。对于抗体阳性者,我们进行了一项调查,包括人口统计学特征、COVID-19 暴露和相关症状。采用逻辑回归确定与抗体阳性相关的因素。

结果

11 月 25 日共对 94 名医护人员进行了血清学调查,平均年龄为 34.15 岁(±8.41),大多数(57.44%)为女性。血清阳性率为 18%,大多数(77%)为低风险人群;而高风险人群中,64%检测结果为阴性。低暴露人群产生抗体的可能性是高暴露人群的五倍(OR:5.69;95%CI 1.69-19.13)。年龄和性别与血清阳性率无关。

结论

我们发现 EHCW 中 SARS-CoV-2 抗体的血清阳性率与其他医护人员群体报告的相似。与接触患者较少的 HCW 相比,抗体阳性率更高,因此社区传播的可能性更大。

关键信息

尽管眼科医护人员被认为感染风险更高,但该人群中针对 SARS-CoV-2 的抗体阳性率与之前在其他医护人员群体中报告的相似。

相似文献

1
SARS-CoV-2 seroprevalence in healthcare workers in a high-volume ophthalmology centre in Guatemala.危地马拉一家大容积眼科中心医护人员中 SARS-CoV-2 的血清流行率。
Ann Med. 2021 Dec;53(1):1956-1959. doi: 10.1080/07853890.2021.1993325.
2
SARS-CoV-2 seroprevalence in healthcare workers in a tertiary healthcare network in Victoria, Australia.澳大利亚维多利亚州一个三级保健网络中卫生保健工作者的 SARS-CoV-2 血清流行率。
Infect Dis Health. 2021 Aug;26(3):208-213. doi: 10.1016/j.idh.2021.03.004. Epub 2021 Apr 13.
3
A cross-sectional study of SARS-CoV-2 seroprevalence among asymptomatic healthcare workers in a tertiary healthcare centre: Assessing the impact of PPE guidelines.横断面研究:三级保健中心无症状医护人员中 SARS-CoV-2 血清流行率:评估 PPE 指南的影响。
Indian J Med Microbiol. 2021 Oct-Dec;39(4):528-533. doi: 10.1016/j.ijmmb.2021.09.011. Epub 2021 Oct 20.
4
SARS-CoV-2 seroprevalence and asymptomatic viral carriage in healthcare workers: a cross-sectional study.SARS-CoV-2 血清流行率和医护人员无症状病毒携带情况:一项横断面研究。
Thorax. 2020 Dec;75(12):1089-1094. doi: 10.1136/thoraxjnl-2020-215414. Epub 2020 Sep 11.
5
Prevalence of antibodies to SARS-CoV-2 in Irish hospital healthcare workers.爱尔兰医院医护人员中 SARS-CoV-2 抗体的流行情况。
Epidemiol Infect. 2021 Apr 27;149:e157. doi: 10.1017/S0950268821000984.
6
Seroprevalence of SARS-CoV-2 antibodies and associated factors in healthcare workers: a systematic review and meta-analysis.医护人员中 SARS-CoV-2 抗体的血清流行率及相关因素:系统评价和荟萃分析。
J Hosp Infect. 2021 Feb;108:120-134. doi: 10.1016/j.jhin.2020.11.008. Epub 2020 Nov 16.
7
The seroprevalence of SARS-CoV-2 in a rural southwest community.农村西南社区 SARS-CoV-2 的血清阳性率。
J Osteopath Med. 2021 Feb 1;121(2):199-210. doi: 10.1515/jom-2020-0287.
8
Seroprevalence of SARS-CoV-2 antibodies in over 6000 healthcare workers in Spain.西班牙6000多名医护人员中新型冠状病毒2型抗体的血清阳性率
Int J Epidemiol. 2021 May 17;50(2):400-409. doi: 10.1093/ije/dyaa277.
9
Cross-sectional prevalence of SARS-CoV-2 antibodies in healthcare workers in paediatric facilities in eight countries.八个国家儿科医疗机构医护人员中 SARS-CoV-2 抗体的横断面患病率。
J Hosp Infect. 2021 Apr;110:60-66. doi: 10.1016/j.jhin.2020.12.019. Epub 2021 Jan 7.
10
Prevalence of SARS-CoV-2 Antibody in 2,935 Healthcare Workers at 6 Major Hospitals, Daegu, Korea.韩国大邱6家主要医院2935名医护人员中SARS-CoV-2抗体的流行情况
J Korean Med Sci. 2021 Nov 8;36(43):e294. doi: 10.3346/jkms.2021.36.e294.

引用本文的文献

1
Analysis of the prevalence of anti-SARS-CoV-2 antibodies in groups of medical and non-medical professions.分析医疗和非医疗职业群体中抗 SARS-CoV-2 抗体的流行情况。
Int J Occup Med Environ Health. 2023 Nov 27;36(5):643-655. doi: 10.13075/ijomeh.1896.02162. Epub 2023 Sep 27.

本文引用的文献

1
Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.截至 2020 年 9 月美国估计的 SARS-CoV-2 血清流行率。
JAMA Intern Med. 2021 Apr 1;181(4):450-460. doi: 10.1001/jamainternmed.2020.7976.
2
Implications of COVID-19 for Ophthalmologists.COVID-19 对眼科医生的影响。
Am J Ophthalmol. 2021 Mar;223:108-118. doi: 10.1016/j.ajo.2020.09.027. Epub 2020 Sep 22.
3
Prevalence of SARS-CoV-2 infection in India: Findings from the national serosurvey, May-June 2020.2020 年 5 月至 6 月印度全国血清学调查的 SARS-CoV-2 感染流行率。
Indian J Med Res. 2020;152(1 & 2):48-60. doi: 10.4103/ijmr.IJMR_3290_20.
4
SARS-CoV-2 seroprevalence in oncology healthcare professionals and patients with cancer at a tertiary care centre during the COVID-19 pandemic.SARS-CoV-2 血清流行率在肿瘤学医疗保健专业人员和癌症患者在三级保健中心在 COVID-19 大流行期间。
ESMO Open. 2020 Sep;5(5):e000889. doi: 10.1136/esmoopen-2020-000889.
5
Seroprevalence of immunoglobulin M and G antibodies against SARS-CoV-2 in China.中国 SARS-CoV-2 免疫球蛋白 M 和 G 抗体的血清流行率。
Nat Med. 2020 Aug;26(8):1193-1195. doi: 10.1038/s41591-020-0949-6. Epub 2020 Jun 5.
6
New York City COVID-19 resident physician exposure during exponential phase of pandemic.纽约市 COVID-19 住院医师在大流行指数增长期的暴露情况。
J Clin Invest. 2020 Sep 1;130(9):4726-4733. doi: 10.1172/JCI139587.
7
Interpreting Diagnostic Tests for SARS-CoV-2.解读新型冠状病毒2019(SARS-CoV-2)诊断检测结果
JAMA. 2020 Jun 9;323(22):2249-2251. doi: 10.1001/jama.2020.8259.
8
Preparedness among Ophthalmologists: During and Beyond the COVID-19 Pandemic.眼科医生的准备工作:在新冠疫情期间及之后
Ophthalmology. 2020 May;127(5):569-572. doi: 10.1016/j.ophtha.2020.03.037. Epub 2020 Mar 31.
9
Perspectives on Coronavirus Disease 2019 Control Measures for Ophthalmology Clinics Based on a Singapore Center Experience.基于新加坡一家中心的经验对眼科诊所2019冠状病毒病防控措施的见解
JAMA Ophthalmol. 2020 May 1;138(5):435-436. doi: 10.1001/jamaophthalmol.2020.1288.
10
Precautionary measures needed for ophthalmologists during pandemic of the coronavirus disease 2019 (COVID-19).2019年冠状病毒病(COVID-19)大流行期间眼科医生所需的预防措施。
Acta Ophthalmol. 2020 May;98(3):221-222. doi: 10.1111/aos.14438.